Alzheimer’s Association to Fund Dementia Risk Reduction Trial Mike Splaine reports from #AAIC2017 in London on the news of the Alzheimer’s Association’s $20 million lifestyle intervention trial in the U.S. to prevent cognitive decline: “This announcement continues and extends the trend of public health and the Alzheimer community to move forward swiftly on the evidence… Continue reading Splaine Consulting Updates: July 2017